Advicenne (Euronext: ADVIC), a specialist pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal diseases, today announces the publication of its 2018 annual financial report, which includes the Directors and corporate governance reports.

This report, as well as its IFRS 2018 individual financial statements (in accordance with IFRS as adopted by the EU), are available in electronic version on the Company’s website (www.advicenne.com) under the section ‘Investors’.